Concept:
The clinical scenario of a viral infection (Dengue) that initially improves but is followed by a secondary surge of high unremitting fever, profound cytopenias (thrombocytopenia and leukopenia), and systemic collapse should raise immediate suspicion for secondary Hemophagocytic Lymphohistiocytosis (HLH), also known as Macrophage Activation Syndrome (MAS).
Explanation:
• Hemophagocytic Lymphohistiocytosis (HLH) is a severe, life-threatening hyperinflammatory syndrome caused by the uncontrolled activation of macrophages and T-cells, leading to a massive cytokine storm.
• Secondary HLH is most commonly triggered by viral infections (classically EBV, but increasingly recognized in Dengue, CMV, and HIV), autoimmune diseases, and malignancies.
• To formally diagnose HLH, the HLH-2004 criteria are utilized. Diagnosis requires a molecular diagnosis OR at least 5 of the following 8 criteria:
1. Fever $\geq$ 38.5°C
2. Splenomegaly
3. Cytopenias affecting $\geq$ 2 lineages (Hb $<$ 9, Platelets $<$ 100k, Neutrophils $<$ 1000)
4. Hypertriglyceridemia (fasting $>$ 265 mg/dL) and/or Hypofibrinogenemia ($\leq$ 1.5 g/L)
5. Hemophagocytosis in bone marrow, spleen, or lymph nodes
6. Low or absent NK-cell activity
7. Hyperferritinemia (often $>$ 500 $\mu$g/L, frequently $>$ 10,000)
8. High soluble CD25 (sIL-2R).
• Option (B) lists the exact diagnostic workup required to fulfill the HLH-2004 criteria (Ferritin, Triglycerides, Fibrinogen, NK cell activity, and bone marrow biopsy for hemophagocytosis).
• Options (A), (C), and (D) are non-specific and do not provide the targeted diagnostic panel required for HLH.
Final answer:
To diagnose post-Dengue Hemophagocytic Lymphohistiocytosis, the criteria-specific workup listed in Option (B) must be performed immediately.